Onconova New Letterhead Logo (002).JPG
Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2018 Financial Results
August 07, 2018 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova New Letterhead Logo (002).JPG
Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.
June 21, 2018 08:00 ET | Onconova Therapeutics, Inc.
New Role as the President involves leadership of the entire product portfolioPromotion reflects progress of Rigosertib to key data milestones NEWTOWN, Pa., June 21, 2018 (GLOBE NEWSWIRE) --...
Onconova New Letterhead Logo (002).JPG
Onconova Therapeutics Announces Presentation at the 23rd Congress of the European Hematology Association
June 07, 2018 08:30 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova New Letterhead Logo (002).JPG
Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018
May 03, 2018 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Logo BLUE.jpg
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2017 Financial Results
August 15, 2017 07:00 ET | Onconova Therapeutics
NEWTOWN, Pa., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Therapeutics Announces Closing of Public Offering of Common Stock
April 26, 2017 17:25 ET | Onconova Therapeutics
NEWTOWN, Pa., April 26, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug...
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2016 Financial Results
March 16, 2017 08:30 ET | Onconova Therapeutics
NEWTOWN, Pa., March 16, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel small...